Browsing by Author "Rebillat, Anne-Sophie"

Sort by: Order: Results:

  • Emes, David; Hüls, Anke; Baumer, Nicole; Dierssen, Mara; Puri, Shiela; Russell, Lauren; Sherman, Stephanie L.; Strydom, Andre; Bargagna, Stefania; Brandão, Ana Cláudia; Costa, Alberto C.S.; Feany, Patrick T.; Chicoine, Brian Allen; Ghosh, Sujay; Rebillat, Anne-Sophie; Sgandurra, Giuseppina; Valentini, Diletta; Roher, Tilman R.; Levin, Johannes; Lakhanpaul, Monica; Trisomy Research Society Covid-Initiative Study Group (MDPI, 2021)
    Adults with Down Syndrome (DS) are at higher risk for severe outcomes of coronavirus disease 2019 (COVID-19) than the general population, but evidence is required to understand the risks for children with DS, which is ...
  • Pinku, Halder; Hüls, Anke; Feany, Patrick T.; Baumer, Nicole; Dierssen, Mara; Bargagna, Stefania; Costa, Alberto C.S.; Chicoine, Brian Allen; Rebillat, Anne-Sophie; Sgandurra, Giuseppina; Valentini, Diletta; Rohrer, R. Tilman; Levin, Johannes; Lakhanpaul, Monica; Carfì, Angelo; Sherman, Stephanie L.; Strydom, Andre; Ghosh, Sujay; Trisomy Research Society Covid-Initiative Study Group (International Society of Global Health, 2022)
    Background: People with Down syndrome (DS) are one of the highest risk groups for mortality associated with COVID-19, but outcomes may differ across countries due to different co-morbidity profiles, exposures, and societal ...
  • Gu, Yuchen; Moroy, Gautier; Paul, Jean-Louis; Rebillat, Anne-Sophie; Dierssen, Mara; Torre Fornell, Rafael de la; Cieuta-Walti, Cécile; Dairou, Julien; Janel, Nathalie (MDPI, 2020)
    Epigallocatechin gallate (EGCG) is an inhibitor of DYRK1A, a serine/threonine kinase considered to be a major contributor of cognitive dysfunctions in Down syndrome (DS). Two clinical trials in adult patients with DS have ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking